Jul 08, 2022

Innocoll Announces Strategic Investment from Hillhouse Investment

Jul 06, 2022

Innocoll Announces Publication of Positive Results from Pivotal Clinical Trial of POSIMIR in Arthroscopic Subacromial Decompression

Mar 02, 2022

Innocoll Announces Positive Topline Results for XARACOLL® (bupivacaine hydrochloride) Implant in a Phase 3 Study to Support Expanded Use

Feb 25, 2022

Innocoll Announces Co-Promotion Agreement for Hernia Product Portfolio

Feb 22, 2022

Innocoll Announces Successful Completion of Debt Refinancing